Page 109 - 72_02

VOL. 72 (2), 317-341, 2006 SULFONAMIDA: EL GRUPO MÁGICO

(22) SCHREIBER, R.; MANZE, B.; HAUSSELS, A. y DE VRY, J. (1999): «Effect of the 5-
(23) HT1A receptor agonist ipsapirone on operant self-administration of ethanol
(24) in rat». Eur. Neuropsycopharmacol. 10: 37-42.
(25) DOURADO, K. C.; BESTETTI, R. B.; CORDEIRO, J. A. y THEODOROPOULOS, T. A. (2006):
(26) «Assessment of Quality of Life in patients with chronic heart failure secon-
dary to Chagas’ cardiomyopathy». Int. J. Cardiol. 108: 412-413.
(27) LOMBARDINO, J. G. y WISEMAN, E. H. (1971): «Sudoxicam and related N-hete-
rocyclic carboxamides of 4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide. Potent
(28) nonsteroidal antiinflammatory agents». J. Med. Chem. 15: 848-849.
HROMATKA, O. (1976): Ger. Pat. 2537060.
GIRÁLDEZ, A.; NIEVES, R.; OCHOA, C.; VARA DE REY, C.; CENARRUZABEITIA, E. y
LASHERAS, B. (1989): «Analgesic and antipiretic activities of 1,2,6-thiadiazin-
3-one 1,1-dioxides. SAR design of a new analgesic agent». Eur. J. Med. Chem.
24: 497-502.
CAMPILLO, N.; GARCÍA, C.; GOYA, P.; PÁEZ, J. A.; CARRASCO, E. y GRAU, M. (1999):
«Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2 dioxides as inhibitors of pla-
telet aggregation. 1. Synthesis and pharmacological evaluation». J. Med.
Chem. 42: 1698-1704.
CAMPILLO, N.; GOYA, P. y PÁEZ, J. P. (1999): «Novel arylpyrazino[2,3-c][1,2,6]
thiadiazine 2,2 dioxides as platelet aggregation inhibitors. 2. Optimization by
quantitative structure-activity relatioships». J. Med. Chem. 42: 3279-3288.

341